
Fighting the FDA’s Final Rule on LDTs
CEO Laurie Menser discusses the Association for Molecular Pathology’s court case against the FDA’s rule on laboratory-developed tests.
CEO Laurie Menser discusses the Association for Molecular Pathology’s court case against the FDA’s rule on laboratory-developed tests.
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
Lee Fleisher, MD, advocates for clearer interpretation of test results by medical laboratory scientists
The US Supreme Court decision that recently overturned the Chevron doctrine is influencing potential enactment of new legislation
A lawsuit by a group of herring fishermen upended 40 years of legal precedent regarding how federal agencies interpret statutes